---
schema_version: "secwatch.filing_event.v1"
accession: "0001837607-25-000059"
form_type: "8-K"
ticker: "AEON"
cik: "0001837607"
company_name: "AEON Biopharma, Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T09:01:58.247121+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# AEON Biopharma elects Fischer and Carter as Class II directors; ratifies KPMG

## Summary
- Jost Fischer and Eric Carter elected as Class II directors for three-year terms ending 2028.
- Fischer received 661,774 votes for and 138,295 withheld; Carter 674,894 for and 125,175 withheld.
- KPMG ratified as independent auditor for FY 2025 with 4,956,438 for, 170,672 against, 30,177 abstain.

## SEC filing metadata
- accession: 0001837607-25-000059
- form_type: 8-K
- ticker: AEON
- cik: 0001837607
- company_name: AEON Biopharma, Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1837607/000183760725000059/0001837607-25-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1837607/000183760725000059/aeon-20250613x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001837607-25-000059
- JSON: https://secwatch.observer/filing/0001837607-25-000059.json
- Plain text: https://secwatch.observer/filing/0001837607-25-000059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.